Procaps Group (Procaps Group) Days Inventory : 184.04 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Procaps Group Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Procaps Group's Average Total Inventories for the three months ended in Sep. 2023 was $100.9 Mil. Procaps Group's Cost of Goods Sold for the three months ended in Sep. 2023 was $50.0 Mil. Hence, Procaps Group's Days Inventory for the three months ended in Sep. 2023 was 184.04.

The historical rank and industry rank for Procaps Group's Days Inventory or its related term are showing as below:

PROC' s Days Inventory Range Over the Past 10 Years
Min: 150.71 Med: 167.55 Max: 195.28
Current: 195.28

During the past 4 years, Procaps Group's highest Days Inventory was 195.28. The lowest was 150.71. And the median was 167.55.

PROC's Days Inventory is ranked worse than
64.61% of 972 companies
in the Drug Manufacturers industry
Industry Median: 157.72 vs PROC: 195.28

Procaps Group's Days Inventory declined from Sep. 2022 (212.54) to Sep. 2023 (184.04).

Inventory Turnover measures how fast the company turns over its inventory within a year. Procaps Group's Inventory Turnover for the three months ended in Sep. 2023 was 0.50.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Procaps Group's Inventory-to-Revenue for the three months ended in Sep. 2023 was 0.85.

Procaps Group Days Inventory Historical Data

The historical data trend for Procaps Group's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procaps Group Days Inventory Chart

Procaps Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Days Inventory

166.74

168.35

150.71

188.83

Procaps Group Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Inventory	Get a 7-Day Free Trial											212.54	182.82	234.69	189.17	184.04

Competitive Comparison of Procaps Group's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Procaps Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Procaps Group's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Procaps Group's Days Inventory distribution charts can be found below:

* The bar in red indicates where Procaps Group's Days Inventory falls into.

Procaps Group Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Procaps Group's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as

	Days Inventory (A: Dec. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2021 )	+	Total Inventories (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (79.43	+	96.833)	/	2 )	/	170.351	*	365
=	88.1315					/	170.351	*	365
=	188.83

Procaps Group's Days Inventory for the quarter that ended in Sep. 2023 is calculated as:

	Days Inventory (Q: Sep. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (103.475	+	98.242)	/	2 )	/	50.007	*	365 / 4
=	100.8585					/	50.007	*	365 / 4
=	184.04

Procaps Group (NAS:PROC) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Procaps Group's Inventory Turnover for the three months ended in Sep. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	50.007	/	100.8585
	=	0.50

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Procaps Group's Inventory to Revenue for the three months ended in Sep. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	100.8585	/	118.41
	=	0.85

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Procaps Group Days Inventory Related Terms

Thank you for viewing the detailed overview of Procaps Group's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Procaps Group (Procaps Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procaps Group SA (NAS:PROC) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

9X1:Germany

Address

9 Rue de Bitbourg, Luxembourg, LUX, L-1273

Website

https://www.procapsgroup.com

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Executives

Alexandre Weinstein Manieu	director, 10 percent owner	CHASHAM PLACE, FLAT 1, LONDON X0 SW1X 8HG
Ruben Minski	director, 10 percent owner, officer: Chief Executive Officer	9 RUE DE BITBOURG, C/O PROCAPS GROUP, S.A., LUXEMBOURG N4 L-1273
Jose Minski	director, 10 percent owner	9 RUE DE BITBOURG, C/O PROCAPS GROUP, S.A., LUXEMBOURG N4 L-1273
Sognatore Trust	10 percent owner	OFICINA 503A-02, EDIFICIO QUANTUM, (500) RUTA 8 KM. 17.500 ZONAMERICA, MONTEVIDEO X3 91600
Simphony Trust	10 percent owner	29 BANCROFT MILLS ROAD, WILMINGTON DE 19806
Deseja Trust	10 percent owner	29 BANCROFT MILLS ROAD, WILMINGTON DE 19806
Hoche Partners Pharma Holding S.a.	10 percent owner	3A VAL SAINTE CROIX, LUXEMBOURG N4 L-1371